Aflivu 2 mg

AFLIVU 2 MG is an intravitreal solution containing aflibercept, used for ophthalmic conditions. This medication is designed to target specific proteins in the eye to manage certain retinal disorders.

AFLIVU 2 MG is primarily used for the treatment of wet age-related macular degeneration (AMD) and other retinal conditions. It works by inhibiting vascular endothelial growth factor (VEGF), which can help reduce abnormal blood vessel growth in the retina. This medication is administered via intravitreal injection, directly into the eye, by a healthcare professional.

Common effects of AFLIVU 2 MG may include temporary vision disturbances, eye redness, or discomfort following the injection. Some patients may also experience floaters or increased intraocular pressure. These effects are generally mild and resolve on their own, but persistent or severe symptoms should be reported to a healthcare provider.

AFLIVU 2 MG should be used with caution in patients with a history of eye infections or inflammation. It is important to follow the healthcare provider's instructions for post-injection care to minimize the risk of infection. Patients should also inform their healthcare provider about any allergies or other medications they are taking before receiving this treatment.

AFLIVU 2 MG may interact with other medications, particularly those that affect the immune system or blood clotting. Patients should avoid using this medication with other eye treatments unless directed by a healthcare provider. Alcohol and certain supplements may also influence the effectiveness or safety of this medication.